Published June 27, 2024
| Version v1
Figure
Open
Figure 1 from: Dadanbekova D, Zhakipbekov K, Kodasbayev A, Datkhayev U, Petrova G, Tachkov K (2024) Quality of life of patients with cardiomyopathy treated with sacubitril/valsartan vs. standard therapy during or after COVID-19 in Kazakhstan. Pharmacia 71: 1-6. https://doi.org/10.3897/pharmacia.71.e125055
Authors/Creators
- 1. NPJSC "S. D. Asfendiyarov Kazakh National Medical University", Almati, Kazakhstan
- 2. Medical University – Sofia, Sofia, Bulgaria
Description
Figure 1 Graphical presentation of the linear regression analysis.
Files
big_1080696.jpg
Files
(268.6 kB)
| Name | Size | Download all |
|---|---|---|
|
md5:941e8d08becba25066c8f7dff0e4e3bf
|
268.6 kB | Preview Download |
Additional details
Related works
- Is part of
- Journal article: 10.3897/pharmacia.71.e125055 (DOI)
- Journal article: https://zenodo.org/record/12590804 (URL)